Restrictive Cardiomyopathy

Restrictive cardiomyopathy is the least frequent of the classic cardiomyopathy phenotypes, but it rewards careful technique more than almost any other, since its defining Doppler pattern overlaps substantially with constrictive pericarditis — a condition with an entirely different treatment. See Introduction to Diseases of the Myocardium for how RCM fits into the broader phenotype framework this page builds on.

Definition — and a Distinction Worth Making Precisely

RCM describes an abnormally steep rise in intraventricular pressure for small increases in volume, in the presence of normal or decreased diastolic LV volume and normal ventricular wall thickness.

“Restrictive cardiomyopathy” (the disease) and “restrictive filling” (a Doppler pattern) are genuinely not synonyms, and conflating them is a real source of diagnostic error. A restrictive transmitral filling pattern can occur in dilated cardiomyopathy and in advanced hypertrophic cardiomyopathy too — in both cases, the preferred terminology is “DCM with restrictive physiology” or “HCM with restrictive physiology,” not a relabeling as RCM itself. Conversely, a meaningful number of patients with genuine myocardial infiltrative or storage disease never manifest a restrictive filling pattern at all, particularly early in their disease course — the Doppler finding and the underlying disease can each be present without the other.

Etiology

The pattern of causes differs by population, worth knowing specifically rather than treating RCM as a single etiologic bucket:

• In adults undergoing cardiac transplantation, the most common causes, in descending order, are idiopathic, amyloidosis, sarcoidosis, and radiation- or chemotherapy-related injury.
• In non-transplant populations, RCM is often an autosomal dominant genetic trait, most frequently from mutations in cardiac sarcomere protein genes — troponin I, troponin T, α-actin, and β-myosin heavy chain — the same genes implicated in HCM. A smaller number of cases arise from mutations in desmin, an intermediate filament protein, often accompanied by skeletal myopathy and cardiac conduction system abnormalities.

Secondary myocardial infiltrative and storage disorders are not classified among the primary cardiomyopathic diseases, but they’re responsible for most of the recognizable, named causes of RCM — and the anatomic distinction between the two categories is genuinely useful for keeping the causes straight:

• Infiltrative disorders deposit abnormal material in the interstitial space between myocytes — the prototype is amyloidosis.
• Storage disorders deposit material inside the myocytes themselves — Fabry disease, hemochromatosis, glycogen storage disease, and Niemann-Pick disease are all storage disorders, genuinely distinct from amyloidosis despite superficially similar echo appearances, and genuinely distinct from each other (Fabry disease is not itself a glycogen storage disease, though both can produce a similar increased-wall-thickness phenotype).

Category	Examples
Idiopathic	—
Infiltrative	Amyloidosis (AL, hereditary ATTR, wild-type/senile ATTR), sarcoidosis
Storage	Fabry disease, hemochromatosis, glycogen storage disease, mucopolysaccharidosis, Niemann-Pick disease
Endomyocardial/fibrotic	Endomyocardial fibrosis (with or without hypereosinophilia), Löffler endocarditis, endocardial fibroelastosis, carcinoid heart disease, radiation, chemotherapy
Systemic/other	Scleroderma, lymphoma, Churg-Strauss disease, pseudoxanthoma elasticum

A few etiology-specific points worth knowing:

• Hemochromatosis-related cardiomyopathy nearly always progresses to a dilated, rather than remaining a purely restrictive, phenotype unless successfully treated — chelation therapy or phlebotomy genuinely changes this trajectory, making early recognition clinically meaningful rather than academic.
• Sarcoidosis can present with restrictive physiology that progresses to systolic impairment in its chronic phase — and in this late phase, the standard diagnostic tests for sarcoidosis (serum ACE, non-caseating granuloma on endomyocardial biopsy) can be normal, a genuine false-negative risk worth remembering before ruling out sarcoid based on a negative late-stage workup.
• Endomyocardial fibrosis without hypereosinophilia is endemic in tropical and subtropical regions (Africa, India, Asia, South and Central America) and rare elsewhere, typically affecting adolescents and young adults with an insidious onset progressing to biventricular failure — it remains a significant cause of cardiovascular death in the second and third decades of life in endemic regions.

Echocardiographic Features

The characteristic appearance is marked biatrial dilation with a non-hypertrophied, non-dilated LV and normal or only mildly reduced radial systolic function. Thrombus in the atrial appendages is a recognized associated finding.

Ejection fraction can be entirely normal in early disease — but abnormalities in longitudinal function and torsion, detectable by tissue Doppler and speckle-tracking strain, are frequently present even when radial fractional shortening still looks preserved. In other words, longitudinal dysfunction precedes radial dysfunction in RCM, which is exactly why relying on EF or fractional shortening alone can miss meaningful early disease. In advanced disease, severe global LV systolic impairment can eventually develop. Echocardiographically detected abnormal systolic function (via strain) has its highest prevalence specifically in symptomatic patients.

Doppler Findings

A restrictive mitral inflow pattern — the most severe grade on the LV diastolic function spectrum — E/A ratio ≥2, E-wave deceleration time ≤150 ms, and isovolumic relaxation time ≤70 ms — is the classic, supportive Doppler signature, though, as above, it’s neither universally present nor unique to RCM.

• Pulmonary vein and hepatic vein Doppler show higher diastolic than systolic velocities, increased atrial reversal velocity, and an atrial reversal duration that exceeds the mitral A-wave filling duration.
• Tissue Doppler imaging shows reduced diastolic annular velocities and an increased E/e′ ratio, reflecting elevated LV end-diastolic pressure. Early diastolic tissue Doppler velocity can meaningfully stage disease severity even in asymptomatic patients with a normal ejection fraction — distinguishing non-cardiac involvement, cardiac involvement without heart failure, and cardiac involvement with heart failure along a single continuum, which is genuinely useful for following at-risk patients (gene carriers, for instance) before overt disease develops.

Cardiac Amyloidosis: A Genuinely Distinctive Pattern

Beyond the general RCM picture, amyloidosis adds several additional, recognizable findings worth actively looking for — see Cardiac Amyloidosis for the full diagnostic picture, subtype-specific detail, and reporting framework:

• Thickening of the right atrial wall, the interatrial septum, and the atrioventricular valves
• A pericardial effusion
• The “apical sparing” (or “cherry on top”) pattern of longitudinal strain — severely reduced strain and strain rate throughout most of the ventricle, with the LV apex relatively spared. In one illustrative case, average global strain was as severely reduced as −5%, with the apex standing out as the one segment still functioning relatively normally. This pattern, combined with increased myocardial echogenicity (the classic “sparkling” texture), supports the diagnosis — though sparkling alone is neither sensitive nor specific enough to rely on in isolation.

Löffler Endocarditis (Hypereosinophilic Endocarditis)

A distinctive echo pattern of its own, worth recognizing as a specific entity rather than generic RCM: endocardial thickening involving the inflow and apical portions of both ventricles, often with postero-basal LV thickening that limits posterior mitral leaflet motion, and layered thrombus frequently filling the ventricular apices. Systolic function is usually preserved. The mechanism is a progression from eosinophilic degranulation causing endocardial necrosis to eventual fibrosis, generally in the setting of an eosinophil count over 1,500 cells/µL without another explanation. Fibrous endocardial involvement of the RV and/or LV inflow tract commonly produces atrioventricular valve regurgitation as a consequence. A representative diagnostic picture: predominant early diastolic (E-dominant) mitral inflow, reduced tissue Doppler velocities in both systole and diastole, diastolic- only forward hepatic vein flow, and a dilated IVC without respiratory variation — together reflecting markedly elevated right atrial pressure from biventricular diastolic dysfunction.

Endocardial Fibroelastosis

A distinct entity common in tropical Africa and an important regional cause of heart failure there, involving fibrosis of the LV and RV apices that extends to the chordae, the posterior mitral leaflet, and the tricuspid valve. Surgical removal of fibrotic lesions is possible, but outcomes remain poor.

Distinguishing RCM from Constrictive Pericarditis

This is the differential that matters most in practice, since Doppler signals in the two conditions can look very similar despite requiring entirely different treatment — see Constrictive Pericarditis for the full picture from that side of the differential. Both conditions can even share the same invasive “dip and plateau” pressure tracing, which is why echocardiography (not catheterization alone) is often what actually settles the question. Two principles do the real discriminating work, and both follow from the same underlying fact: the myocardium itself is diseased in RCM, but structurally normal in constriction.

Principle 1: Ventricular Interdependence Signs Favor Constriction

Because the heart is enclosed within a relatively fixed pericardial volume in constriction, exaggerated, reciprocal respiratory variation appears that simply isn’t present in RCM:

• Respiratory variation in transmitral early diastolic velocity exceeding 25%
• A rise in tricuspid inflow velocity paired with a fall in mitral inflow velocity during inspiration
• Respiratory variation in pulmonary vein early diastolic velocity exceeding 25%
• Diastolic flow reversal in the hepatic veins specifically during expiration

Principle 2: Early Diastolic Mitral Annular Velocity Points the Opposite Direction in Each Condition

Because myocardial function is genuinely impaired in RCM but preserved in constriction, early diastolic mitral annular velocity (e′) is reduced in RCM and normal or even increased in constriction — the same “annulus paradoxus” phenomenon described on the constrictive pericarditis page, approached here from the opposite side of the differential. An illustrative contrast: e′ of 4 cm/s is consistent with RCM, while e′ of 12 cm/s is consistent with constriction. Tissue Doppler velocity and strain in the lateral LV and RV walls follow the same logic — normal in constrictive pericarditis, impaired in RCM. A longitudinal expansion velocity (Ea) over 8.0 cm/s specifically suggests constriction.

Associated Hemodynamic Findings

• Elevated filling pressures — a dilated IVC with reduced or absent inspiratory collapse, with right atrial pressure inferred accordingly. See Evaluation of the Left Atrium for the broader atrial assessment framework that the marked biatrial dilation here builds on.
• Pulmonary hypertension, secondary to chronically elevated left-sided filling pressure, estimated from the tricuspid regurgitant jet in the standard way.
• No segmental wall motion abnormality — a useful point of distinction from ischemic heart disease, since RCM’s systolic impairment, when present, is global rather than regional.
• A “dip and plateau” pattern can be seen on invasive LV diastolic pressure recordings, reflecting the rapid rise in early diastolic pressure once the mitral valve opens — as noted above, this invasive finding is shared with constriction, which is exactly why Doppler echo carries so much of the differential-diagnosis burden here.

Beyond Echo: CMR and Endomyocardial Biopsy

Cardiac MRI adds tissue characterization that echo cannot — late gadolinium enhancement patterns support specific etiologies, including amyloidosis and sarcoidosis, complementing the echo findings above rather than replacing them. Endomyocardial biopsy is reserved for cases where a definitive histologic diagnosis is specifically required and can’t be reached by imaging and laboratory testing alone — amyloidosis and sarcoidosis are the two etiologies most often driving this decision.

A Genuine Therapeutic Tension Worth Understanding

Patients with RCM often need rate-slowing medication for the conduction disease and tachyarrhythmias that frequently accompany it — but because stroke volume is fixed by the restrictive physiology itself, heart rate is what maintains cardiac output, so further slowing it can reduce output at exactly the point the patient can least afford it. This is a genuine tension in management, not a reason to avoid rate control altogether, and it’s worth understanding rather than applying standard heart-failure reflexes here. ACE inhibitors and ARBs are specifically not indicated in this population and carry a real risk of hypotension, unlike their central role in standard HFrEF management — another reminder that RCM’s physiology doesn’t simply mirror more common heart failure phenotypes. Diuretics help relieve congestion but should be used cautiously, since reducing preload too aggressively in a ventricle that depends on adequate filling to generate any stroke volume at all can itself lower cardiac output. LVAD support is rarely a viable option, precisely because the small, stiff ventricular cavity that defines RCM doesn’t provide adequate inflow for a device designed around a larger, more compliant chamber. Treating the underlying cause — chelation or phlebotomy for hemochromatosis, immunosuppression for sarcoidosis, disease-specific therapy for amyloidosis — is the most direct way to change the trajectory when a specific etiology has been identified.

Clinical Importance

RCM’s real diagnostic challenge isn’t recognizing a restrictive Doppler pattern — it’s recognizing when that pattern does and doesn’t mean what it appears to mean. The same signature can appear in advanced DCM or HCM without representing RCM at all, genuine RCM can be present without ever producing a classic restrictive pattern, and the single most consequential differential — constrictive pericarditis — can share nearly identical Doppler findings while demanding an entirely different treatment. Getting this right rests on the same discipline threaded through every page in this section: let the mechanism, not the pattern-matching, drive the diagnosis.